| # | Drug | Count |
|---|---|---|
| 0 | CITALOPRAM | 571 |
| 1 | CITALOPRAM HYDROBROMIDE | 565 |
| 2 | TOCILIZUMAB | 530 |
| 3 | BUPROPION HYDROCHLORIDE | 513 |
| 4 | ACETAMINOPHEN | 501 |
| 5 | DIPHENHYDRAMINE HYDROCHLORIDE | 495 |
| 6 | MONTELUKAST SODIUM | 494 |
| 7 | PROGESTERONE | 494 |
| 8 | RITUXIMAB | 483 |
| 9 | CETIRIZINE HYDROCHLORIDE | 482 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RICINUS COMMUNIS | 2 | 0.5000 |
| 1 | ABACAVIR , LAMIVUDINE AND ZIDOVUDINE | 1 | 0.1000 |
| 2 | PSYLLIUM HUSK | 117 | 0.0866 |
| 3 | METHYLPREDNISOLONE ACETATE | 407 | 0.0501 |
| 4 | NORTRIPTYLINE HYDROCHLORIDE | 285 | 0.0478 |
| 5 | BETAMETHASONE DIPROPIONATE USP, 0.05% | 1 | 0.0476 |
| 6 | ABACAVIR AND LAMIVUDINE | 9 | 0.0450 |
| 7 | OXYCODONE AND ASPIRIN | 2 | 0.0392 |
| 8 | CYCLOBENZAPRINE HYDROCHLORIDE | 337 | 0.0359 |
| 9 | KETOPROFEN | 481 | 0.0358 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 625 |
| 1 | Benzodiazepine [EPC] | 558 |
| 2 | Vitamin C [EPC] | 548 |
| 3 | Interleukin-6 Receptor Antagonist [EPC] | 530 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 505 |
| 5 | Progesterone [EPC] | 494 |
| 6 | Selective T Cell Costimulation Modulator [EPC] | 478 |
| 7 | Central alpha-2 Adrenergic Agonist [EPC] | 430 |
| 8 | Expectorant [EPC] | 417 |
| 9 | Histamine-1 Receptor Antagonist [EPC] | 393 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Progesterone [EPC] | 494 | 0.0208 |
| 1 | Leukotriene Receptor Antagonist [EPC] | 268 | 0.0092 |
| 2 | Central alpha-2 Adrenergic Agonist [EPC] | 430 | 0.0080 |
| 3 | Histamine-1 Receptor Antagonist [EPC] | 393 | 0.0047 |
| 4 | Cortisol Synthesis Inhibitor [EPC] | 3 | 0.0040 |
| 5 | Interleukin-6 Receptor Antagonist [EPC] | 530 | 0.0038 |
| 6 | Selective T Cell Costimulation Modulator [EPC] | 478 | 0.0034 |
| 7 | Oxytocic [EPC] | 9 | 0.0030 |
| 8 | Serotonin-3 Receptor Antagonist [EPC] | 305 | 0.0022 |
| 9 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 105 | 0.0021 |